Skip to content

Calibr-Ì: Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans

Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06454617
Acronym
Calibr-Ì
Enrollment
100
Registered
2024-06-12
Start date
2024-06-06
Completion date
2026-06-30
Last updated
2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

Osteoporosis is a systemic disease characterized by a reduction in bone mineral density (BMD) and qualitative alteration of the skeleton, resulting in increased bone fragility and fracture risk. The epidemiological impact of osteoporosis is extremely high. Proper diagnosis and clinical management of osteoporosis are critical to reducing the incidence of fragility fractures and preventing their complications. The diagnosis is generally confirmed by instrumental analysis of bone mineral density. The standard method is X-ray bone densitometry (DXA), which allows diagnosis based on criteria defined by the World Health Organization (WHO) by virtue of the T-score. DXA is a relatively quick and inexpensive examination with low exposure to ionizing radiation. However, this method has limitations in detecting fracture risk, and in addition, not all patients are properly referred for DXA services, which, among other things, require specific criteria to be reimbursed by the National Health System. Currently, computed tomography (CT) scanning is the most widely used three-dimensional diagnostic modality in clinical practice, and the number of investigations performed in high-income countries is continuously growing. Quantitative assessment of bone mineral density by CT is possible by proper calibration of the machine for the purpose of converting the CT numbers (or Hounsfield units) measured by the scanner into BMD units.

Interventions

OTHERPhantom

The patients will be simultaneously scanned with a QCT phantom

Sponsors

Auckland Hospital - Greenlane Clinical Centre - National Women's Hospital
CollaboratorUNKNOWN
Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Both sexes. * All ethnicities. * Age equal or above 18 years. * Any clinical indication (no specific pathology is required) for a CT scan of the lumbosacral spine or abdomen in which the entire lumbar spine (L1 to L5), paravertebral muscles, abdominal aorta, and subcutaneous adipose tissue are visible. * Ability to give informed consent.

Exclusion criteria

* General contraindications to CT examination, including pregnancy or body weight/size exceeding scanner limits. * Severe degenerative manifestations of the lumbosacral spine. * Severe scoliosis of the lumbosacral spine. * Surgical hardware that prevents adequate CT scanning. * Oncologic pathology in progress or in recent history. * Any other situation deemed incompatible with the study by the designated physician or investigator.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of different internal calibration methodsAt baseline (Day 0)Compare the different methods of internal or phantomless calibration described in the literature with synchronous and asynchronous calibration in a population of patients undergoing CT scans that include the lumbar spine to assess their feasibility.

Secondary

MeasureTime frameDescription
Definition of performance of internal calibration methodsAt baseline (Day 0)Define the performance of various internal or phantomless calibration methods for the purpose of identifying the most appropriate and reliable technique.
Optimization of existing internal calibration methodsThrough study completion, up to 2 yearsOptimize existing internal calibration methods, and eventually define a new phantomless targeted calibration protocol based on the results of the study.

Countries

Italy, New Zealand

Contacts

Primary ContactAlberto Bazzocchi, MD
alberto.bazzocchi@ior.it051636
Backup ContactRebecca Sassi, MSc
rebecca.sassi@ior.it051636

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026